AUG 6, 2026 · PHASE 1/2 TRIAL
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
ClinicalTrials.gov
This is an active Phase 1/2 trial registration with no results posted; it describes planned enrollment and safety/efficacy endpoints but reports no outcome data.
Reported
Planned enrollment140
Primary outcome measure 1Number of Participants Who Experience a Dos…
Primary outcome measure 2Number of Participants Who Experience an Ad…